FNY Investment Advisers’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194K Hold
6,800
0.07% 244
2026
Q1
$214K Sell
6,800
-20,000
-75% -$630K 0.09% 192
2025
Q4
$789K Buy
26,800
+20,000
+294% +$556K 0.22% 103
2025
Q3
$171K Buy
6,800
+5,000
+278% +$122K 0.06% 296
2025
Q2
$43K Hold
1,800
0.02% 432
2025
Q1
$41K Sell
1,800
-200
-10% -$4.83K 0.03% 311
2024
Q4
$50K Hold
2,000
0.03% 333
2024
Q3
$49K Buy
+2,000
New +$59.2K 0.02% 283

Other funds holding RTO

FNY Investment Advisers's RTO Position: Q2 2026 in Review

FNY Investment Advisers held its Rentokil (RTO) position steady in Q2 2026 at 6,800 shares worth $194K. The position accounts for 0.07% of the portfolio, ranked #244.

FNY Investment Advisers first reported a position in RTO in Q3 2024 and has held it in 8 quarters since. The position peaked at $789K in Q4 2025. 23 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • FNY Investment Advisers held 6,800 shares of Rentokil worth $194K as of Q2 2026.
  • FNY Investment Advisers left its Rentokil share count unchanged in Q2 2026.
  • Rentokil made up 0.07% of FNY Investment Advisers's portfolio in Q2 2026, its #244 holding.
  • FNY Investment Advisers first reported a position in Rentokil in Q3 2024 and has held it in 8 quarters since.
  • FNY Investment Advisers's Rentokil position peaked at $789K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.